| answer text |
<p>We are aware of ongoing intermittent supply issues with Creon 25000 gastro-resistant
capsules. These are due to manufacturing and active pharmaceutical ingredient constraints.
The supplier has confirmed that stock of Creon 25000 gastro resistant capsules is
now available, with further deliveries scheduled in May 2024. The Department has issued
guidance to healthcare professionals regarding treatment of patients, while there
was disruption to the supply of Creon 25000 gastro-resistant capsules. We continue
to explore all management options to manage this issue. We have asked the supplier
to continue confirming their future forecasts, and to inform us of any further gaps
in supply of Creon 25000 gastro-resistant capsules.</p><p>Whilst we can’t always prevent
supply issues, we have a range of well-established tools and processes to mitigate
risks to patients. These include close and regular engagement with the suppliers,
use of alternative strengths or forms of a medicine to allow patients to remain on
the same product, expediting regulatory procedures, sourcing unlicensed imports from
abroad, adding products to the restricted exports and hoarding list, use of Serious
Shortage Protocols (SSPs), and issuing NHS communications to provide management advice
and information on the issue to healthcare professionals, so they can advise and support
their patients.</p>
|
|
